RSPO3 and metabolic dysfunction-associated steatotic liver disease: RSPO3 mRNA, but not RSPO1, RSPO2 and RSPO4 mRNA, showed significant positive correlations with WNT-target gene expression in multiple cohorts of patients with MASLD (Fig. 5j and Extended Data Fig. 12b–e).